Skip to content
Skip to content

Care line · Hair

Hair loss is a forever-subscription. Your audience already pays it.

Finasteride and minoxidil — treatment that works only while it continues, which makes it one of the most durable subscriptions in consumer health. Embed Care runs it under your brand, end to end.

Licensed clinician

Hair visits

4.6/5 patient rating

Reviewed in 15–60 min

Licensed in all 50 states

Why hair earns its place

Broad, evergreen demand

Half of men see hair loss by 50 — an entry point that converts casual audiences, not just the health-obsessed.

Retention is the mechanism

Stopping treatment means losing ground — adherence is medically motivated, not marketing-driven.

The easy first yes

Low price, low friction, familiar medications — the line that opens the relationship for everything else.

The people

Licensed clinicians. Happy patients. Your brand between them.

Every hair visit is reviewed by a licensed clinician, routed by state licensure and specialty in 15–60 minutes, around the clock. Patients rate the experience 4.6/5 — under your brand, not ours.

4.6/5 patient-rated care
I put this off for years because of the pharmacy counter. This was private and fast — now it's just a habit.
Hair program member · illustrative

The menu, ready to sell.

See it in a live store

Finasteride

Daily tablet that stops hair loss at the source.

Daily tablet

Minoxidil

Topical that stimulates regrowth.

Topical

You set patient retail within a floor and cap; a licensed clinician determines eligibility and treatment. Compounded medications are not FDA-approved.

Built for audiences like yours.

The whole-care turn

They come for the hairline. They stay for skin, hormones, and primary care — the entry subscription that starts a lasting clinical relationship.

Do the math on your audience.

Drag the slider to your reach. At a conservative 2% of people already buying this care, the recurring revenue is yours to keep — we charge flat product rates.

yourbrand.com

Revenue Engine

Adjust your audience size to see potential returns.

250,000
10k1M+
Estimated Recurring Revenue
$0/ mo
Patients Enrolled0At 2% conversion
Lifetime Value$0Based on 6mo retention

Modeled on a representative blended program mix across care lines — DTC GLP-1 subscriptions alone run ~$199/mo in the market. Illustrative estimate only; actual results vary with conversion, retention, pricing, and medication costs. Not guaranteed earnings.

The easiest first yes in consumer health — under your brand.